• Je něco špatně v tomto záznamu ?

Pigments from Filamentous Ascomycetes for Combination Therapy

R. Hromádka, Z. Kejík, M. Jakubek, R. Kaplánek, V. Šandriková, M. Urban, P. Martásek, V. Král,

. 2019 ; 26 (20) : 3812-3834. [pub] -

Jazyk angličtina Země Spojené arabské emiráty

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19045511

Filamentous ascomycetes (Neurospora and Monascus) have been studied for a long time because of their production of secondary metabolites such as microbial pigments. The ascomycetes represent an interesting group of compounds with high potential for medicinal applications. Many recent studies have shown their efficacy in the treatment of serious pathological states such as oncological diseases, neurodegenerative diseases and hyperlipidaemia. Nevertheless, the clinical usability of ascomycetes is still limited. However, this problem can be solved by the use of these compounds with combinations of other therapeutic agents. This strategy can suppress their side effects and improve their therapeutic efficacy. Moreover, their co-application can significantly enhance conventional therapies that are used. This review summarizes and discusses the general principles of this approach, introduced and supported by numerous examples. In addition, the prediction of the future potential application of this methodology is included.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19045511
003      
CZ-PrNML
005      
20200113082321.0
007      
ta
008      
200109s2019 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/0929867325666180330091933 $2 doi
035    __
$a (PubMed)29600749
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Hromádka, Róbert $u C2P s.r.o. Jungmannova 101 503 51 Chlumec nad Cidlinou, Czech Republic.
245    10
$a Pigments from Filamentous Ascomycetes for Combination Therapy / $c R. Hromádka, Z. Kejík, M. Jakubek, R. Kaplánek, V. Šandriková, M. Urban, P. Martásek, V. Král,
520    9_
$a Filamentous ascomycetes (Neurospora and Monascus) have been studied for a long time because of their production of secondary metabolites such as microbial pigments. The ascomycetes represent an interesting group of compounds with high potential for medicinal applications. Many recent studies have shown their efficacy in the treatment of serious pathological states such as oncological diseases, neurodegenerative diseases and hyperlipidaemia. Nevertheless, the clinical usability of ascomycetes is still limited. However, this problem can be solved by the use of these compounds with combinations of other therapeutic agents. This strategy can suppress their side effects and improve their therapeutic efficacy. Moreover, their co-application can significantly enhance conventional therapies that are used. This review summarizes and discusses the general principles of this approach, introduced and supported by numerous examples. In addition, the prediction of the future potential application of this methodology is included.
650    _2
$a zvířata $7 D000818
650    _2
$a Ascomycota $x chemie $x metabolismus $7 D001203
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a lidé $7 D006801
650    _2
$a biologické pigmenty $x metabolismus $x terapeutické užití $7 D010860
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kejík, Zdeněk $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic.
700    1_
$a Jakubek, Milan $u BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic. Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.
700    1_
$a Kaplánek, Robert $u BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic. Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.
700    1_
$a Šandriková, Viera $u C2P s.r.o. Jungmannova 101 503 51 Chlumec nad Cidlinou, Czech Republic.
700    1_
$a Urban, Marian $u Food Research Institute Prague, Radiova 1285/7, 1285/7, Prague 10, Czech Republic.
700    1_
$a Martásek, Pavel $u Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 2, Czech Republic.
700    1_
$a Král, Vladimír $u BIOCEV, First Faculty of Medicine, Charles University, Prumyslova 595, 252 50 Vestec, Czech Republic. Department of Analytical Chemistry, Faculty of Chemical Engineering, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic.
773    0_
$w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 26, č. 20 (2019), s. 3812-3834
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29600749 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113082652 $b ABA008
999    __
$a ok $b bmc $g 1483779 $s 1084184
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 26 $c 20 $d 3812-3834 $e - $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Možnosti archivace